Antioxidant, anticancer and apoptotic effects of the Bupleurum chinense root extract in HO-8910 ovarian cancer cells

Journal of B.U.ON.

Volumn 20, Issue 5, 2015, Pages 1341-1349

  Gu, Ling Yun ^a   Chen, Zheng ^a   Zhao, Jing ^a   Ruan, Xin Jian ^a   Zhao, Shu Yun ^a   Gao, Hui ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Antioxidant; Apoptosis; Bupleurum chinense; Mitochondria; Ovarian cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIOXIDANT; ASCORBIC ACID; BUPLEURUM ROOT EXTRACT; LIPOCORTIN 5; PLANT EXTRACT; SCAVENGER;

ABTS RADICAL SCAVENGING ASSAY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BUPLEURUM CHINENSE; CELL STRUCTURE; CELL VIABILITY; CHROMATIN CONDENSATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DPPH RADICAL SCAVENGING ASSAY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GEL ELECTROPHORESIS; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NONHUMAN; OVARIAN CANCER CELL LINE; OVARY CANCER; PHASE CONTRAST MICROSCOPY; BUPLEURUM; DOSE RESPONSE; DRUG EFFECTS; FEMALE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PATHOLOGY; PLANT ROOT; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTIOXIDANTS; APOPTOSIS; BUPLEURUM; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, FLUORESCENCE; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PLANT EXTRACTS; PLANT ROOTS;

EID: 84953852778     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Silber JH, Rosenbaum PR, Polsky D et al. Does ovarian cancer treatment and survival differ by the specialty providing chemotherapy? J Clin Oncol 2007;25:1169-1175.
2. Herzog TJ, Pothuri B. Ovarian cancer: a focus on management of recurrent disease. Nat Clin Pract Oncol 2006;3:604-611.
3. Chien JR, Aletti G, Bell DA, Keeney GL, Shridhar V, Hartmann LC. Molecular pathogenesis and therapeutic targets in epithelial ovarian cancer. J Cell Biochem 2007;102:117-129.
4. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc 2007;82:751-770.
5. Donaldson KL, Goolsby GL, Wahl AF. Cytotoxicity of the anticancer agents cisplatin and taxol during cell proliferation and the cell cycle. Int J Cancer 1994;57:847-855.
6. Chen H, Hardy TM, Tollefsbol TO. Epigenomics of ovarian cancer and its chemoprevention. Front Genet 2011;2:67.
7. Goldberg JM, Piver MS, Hempling RE, Recio FO. Paclitaxel and cisplatin combination chemotherapy in recurrent epithelial ovarian cancer. Gynecol Oncol 1996;63:312-317.
8. Milross CG, Peters LJ, Hunter NR, Mason KA, Milas L. Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo. Int J Cancer 1995;62:599-604.
9. Ozols RF. Combination regimens of paclitaxel and the platinum drugs as first-line regimens for ovarian cancer. Semin Oncol 1995;22:1-6.
10. Zhao YY, Luo HS, Wang B, Ma LB, Tu GZ, Zhang RY. Triterpenoid saponins from Bupleurum smithii var. parvifolium. Phytochemistry 1996;42:1673-1675.
11. Guo YJ, Matsumoto T, Kikuchi Y, Ikejima T, Wang BX, Yamada H. Effects of a pectic polysaccharide from a medicinal herb, the roots of Bupleurum falcatum L. on interleukin 6 production of murine B cells and B cell lines. Immunopharmacology 2000;49:307-316.
12. Chinese Herbal Medicine Formulas and Strategies; Bensky & Barolet, Eastland Press, Inc 1990.
13. Benito PB, Martinez MJA, Sen AMS et al. In vivo and in vitro antiinflammatory activity of saikosaponins. Life Sci 1998;63:1147-1156.
14. Yen MH, Lin CC, Yen CM. The immunomodulatory effect of saikosaponins derivatives and the root extract of Bupleurum kaoi in mice. Phytother Res 1995;9:351-358.
15. Huang W, Zhao Y, Sun R. Research development on hepatoprotective effect and hepatotoxicity based on bupleurum saikosaponins components. Chin J Pharmacovigilance 2011;8:38-40.
16. Rang SJ, Lee YJ, Kim BM et al. Effect of Bupleuri Radix extracts on the toxicity of 5-fiuorouracil in HepG2 hepatoma cells and normal human lymphocytes. Basic Clin Pharmacol Toxicol 2008;103:305-313.
17. Wong VK, Li T, Law BY et al. Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells. Cell Death Dis 2013;4:e720.
18. Wang YS. Pharmacology and Applications of Chinese Materia Medica. Beijing: People's Health Publisher, 1983.